Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | ATP-dependent RNA helicase | 0.0107 | 0.0022 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1111 | 0.3364 | 0.335 |
Loa Loa (eye worm) | hypothetical protein | 0.0298 | 0.0658 | 0.0637 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0107 | 0.0022 | 0.0034 |
Brugia malayi | Kelch motif family protein | 0.0298 | 0.0658 | 0.1002 |
Echinococcus granulosus | integrin alpha 3 | 0.1544 | 0.4805 | 1 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0107 | 0.0022 | 0.5 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0107 | 0.0022 | 1 |
Echinococcus multilocularis | integrin alpha 3 | 0.1544 | 0.4805 | 1 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.2014 | 0.637 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0433 | 0.1106 | 0.1087 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0107 | 0.0022 | 0.5 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0107 | 0.0022 | 0.5 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.0688 | 0.1954 | 0.404 |
Echinococcus multilocularis | integrin alpha ps | 0.0903 | 0.2671 | 0.5539 |
Echinococcus granulosus | integrin beta 2 | 0.1453 | 0.4503 | 0.9368 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0107 | 0.0022 | 0.5 |
Schistosoma mansoni | integrin alpha-ps | 0.047 | 0.123 | 0.1932 |
Schistosoma mansoni | hypothetical protein | 0.0433 | 0.1106 | 0.1737 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0107 | 0.0022 | 0.5 |
Echinococcus granulosus | integrin alpha ps | 0.0903 | 0.2671 | 0.5539 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0107 | 0.0022 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.047 | 0.123 | 0.1211 |
Plasmodium vivax | RNA helicase-1, putative | 0.0107 | 0.0022 | 0.5 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0298 | 0.0658 | 0.0637 |
Loa Loa (eye worm) | hypothetical protein | 0.1524 | 0.4737 | 0.4725 |
Schistosoma mansoni | integrin alpha-ps | 0.0903 | 0.2671 | 0.4193 |
Brugia malayi | Integrin beta pat-3 precursor | 0.1772 | 0.5563 | 0.8729 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0107 | 0.0022 | 0.5 |
Schistosoma mansoni | integrin beta subunit | 0.1155 | 0.351 | 0.5511 |
Schistosoma mansoni | integrin alpha | 0.2014 | 0.637 | 1 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0688 | 0.1954 | 0.404 |
Echinococcus multilocularis | integrin beta 2 | 0.1453 | 0.4503 | 0.9368 |
Echinococcus granulosus | integrin alpha ps | 0.0433 | 0.1106 | 0.2267 |
Brugia malayi | hypothetical protein | 0.0298 | 0.0658 | 0.1002 |
Loa Loa (eye worm) | integrin beta-2 | 0.1772 | 0.5563 | 0.5553 |
Echinococcus multilocularis | integrin alpha ps | 0.0433 | 0.1106 | 0.2267 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0107 | 0.0022 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0107 | 0.0022 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1582 | 0.4929 | 0.4918 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0107 | 0.0022 | 0.0034 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.1524 | 0.4737 | 0.7427 |
Echinococcus multilocularis | integrin alpha ps | 0.0903 | 0.2671 | 0.5539 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0107 | 0.0022 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0107 | 0.0022 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0107 | 0.0022 | 0.5 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0107 | 0.0022 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ILS (functional) | = 13 % | Compound is tested against sarcoma 180 ascites (S180a) in female CFW mice, and evaluated for the best percent of increase in life span at optimal dose of 40 mg/kg | ChEMBL. | 2909724 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.